Tachi Yamada, M.D.

Tachi Yamada, M.D. recently led all of Takeda’s research and development activities as the Chief Medical and Scientific Officer. He is currently a venture partner with Frazier Healthcare in Seattle. Prior to Takeda he was the President of the Global Health Program at the Bill & Melinda Gates Foundation. He also served as the Chairman of Research and Development and was a member of the board of directors at GlaxoSmithKline. Earlier, Dr. Yamada was the Chief of the Division of Gastroenterology and the Chair of the Department of Internal Medicine at the University of Michigan in Ann Arbor. In addition to his current role at Frazier and Presage, Dr. Yamada serves as a member of the board of directors at the Clinton Health Access Initiative and a member of the Council of the National Academy of Medicine. He is also a Fellow of the Imperial College of Medicine, a Master of the American College of Physicians, a Fellow of the Royal College of Physicians, and a past-President of the American Gastroenterological Association and the Association of American Physicians.